Search Press releases Keywords From To 18 Nov 2008 Cimzia® studies show significant clinical benefits for mono- and combination therapy in patients with rheumatoid arthritis Read More 31 Oct 2008 Transparency Notification Of UCB's Reference Shareholders Read More 31 Oct 2008 Transparency Declaration by Capital Research and Management Company (CRMC) Read More 31 Oct 2008 Transparency Notification of Wellington Management Company LLP Read More 31 Oct 2008 Fesoterodine approved in the U.S. Read More 31 Oct 2008 UCB on track Read More Pagination First page Previous page Previous … Page 169 Page 170 Page 171 Page 172 Current page 173 Page 174 Page 175 Page 176 Page 177 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
